The Experts

Jun Bei Liu
+ About Jun Bei Liu
Portfolio Manager, Tribeca Investment Partners

Stock of the week

Friday, November 09, 2018

What is the stock?

CSL is Australia’s leading biotechnology company. It is the global leader in the blood plasma therapies sector and the second-largest supplier of seasonal influenza vaccines, with combined annual sales of more than US$7.5 billion.

How long have you held the stock?

We have held it since June 2017.

To continue reading this article, take a free 21-day trial to the Switzer Report. Click here to sign up.